OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Keith Watson is a Principal Consultant at PAREXEL Consulting.
September 01, 2010
Both biosimilar and generic drugs have an abbreviated approval process; however, the clinical trial requirements differ enormously.